Sturm et al. [34] presented no significant differences between TGF-β1 plasma levels in 74 patients with IBD (28 with UC, 45 with CD) in relation to particular phases of the disease and to the control group. This evidence concerns the gene TGFB1 and inflammatory bowel disease.